Well-being - An investor decides to sell Sunrise Medical, foregoing a planned IPO.
Collaborating with the latest owner, the expansion plan will go on, as per the recent announcement. A faster rate of growth is planned across all regions, with a specific emphasis on the key markets. Purchasing other companies is not ruled out. The current management team will stay on board.
Sunrise Medical concentrates on what they call "complex rehabilitation," as they say themselves. Their products are often made specifically for the unique requirements of their clients. Sunrise Medical predicts the entire rehabilitation industry will be worth 5.2 billion euros in 2023.
Read also:
The financial investor chose to sell Sunrise Medical, opting against their planned initial public offering, which was highly anticipated in the German stock exchanges. The decision to sell could potentially impact the health of the rehab industry, given Sunrise Medical's significant market share. In a parallel development, FAZ, a renowned German financial newspaper, reported on the financial consequences of this move for Baden-Württemberg, where Malsch, Sunrise Medical's headquarters, is located. The initial public offering could have brought substantial finances into the region, contributing to its overall development.
